1. Dudley LPC Dan Attry (Chair) & Wyn Wattley (Chief Officer)

2. Community Pharmacy Regulated by acts of Parliament - Medicines Act 1968 - Health Bill 2009 - Pharmaceutical Charter - Controlled by the Royal Pharmaceutical Society -Responsible for “Fitness to Practice” - Responsible for Premises Standards.

3. Role of LPC Statutory body Statutory body Represents all contractors (64) Represents all contractors (64) Negotiating body for dealing with PCT on behalf of all contractors Negotiating body for dealing with PCT on behalf of all contractors

4. New Pharmacy Contract 2005 2005 Essential Services (inc Clin. Governance) Essential Services (inc Clin. Governance) Advanced Services Advanced Services - MURS - MURS AURS AURS Stoma customisation Stoma customisation Enhanced Services Enhanced Services

5. Advanced Services Advanced Services Advanced Services - MURS - MURS AURS AURS Stoma customisation Stoma customisation

6. Enhanced Services Enhanced Services Enhanced Services Smoking Cessation Smoking Cessation Emergency Hormonal Contraception Emergency Hormonal Contraception Chlamydia Screening Chlamydia Screening Brief Alcohol Intervention (pilot) Brief Alcohol Intervention (pilot) Substance Misuse Service Substance Misuse Service Needle Exchange Needle Exchange Care Home support Care Home support

7. PCT Monitoring Visits Annual visit by PCT Annual visit by PCT Compliance questionnaire Compliance questionnaire Quality Quality

8. Funding Global Sum Global Sum - fixed dispensing fee - fixed dispensing fee - MUR - MUR - Max. allowable profit and Cat M effects - Max. allowable profit and Cat M effects Disp. Figures – 5-6% inc. in Rx every year for last 10 years. Disp. Figures – 5-6% inc. in Rx every year for last 10 years.

9. Com Pharmacy Dev. Officer Michelle Dyoss Michelle Dyoss Dual role, innovative, not used any where else in country Dual role, innovative, not used any where else in country Forward thinking LPC Forward thinking LPC Huge leaps in Pharmacy recognition, acceptablility and provision of new services Huge leaps in Pharmacy recognition, acceptablility and provision of new services

10. White Paper 2008 Implications for Pharmacy Implications for Pharmacy “Any willing provider” “Any willing provider”

11. Threats Loss of Remuneration Loss of Remuneration Pharmacy Price Regulation Scheme Pharmacy Price Regulation Scheme Prescribing changes Prescribing changes Supply chain deficiencies Supply chain deficiencies Control of entry Control of entry Category M and PPRS. Category M and PPRS.

12. Opportunities for collaborative working Willingness of LPC members via involvement in various committees Willingness of LPC members via involvement in various committees Areas to work together Areas to work together Health Checks Health Checks Long term conditions Long term conditions Repeat Dispensing / Electronic Prescriptions Repeat Dispensing / Electronic Prescriptions Service Redesign Service Redesign

13. Latest NHS White Paper Commissioning Commissioning Medicines Mgt /CDM Medicines Mgt /CDM NHS Health Checks NHS Health Checks Pharmacists with Special Interests Pharmacists with Special Interests Practice Based Pharmacists? (demise of PCT) Practice Based Pharmacists? (demise of PCT) Services redesign Services redesign

14. The Future Closer working relationship with LMC Closer working relationship with LMC Commissioning Groups – Commissioning Groups – already sitting on old DBC Cluster Forum already sitting on old DBC Cluster Forum Not a competitor, but as partners. Not a competitor, but as partners.

15. Contact Details Chairman – Dan Attry Chairman – Dan Attry 07973 632548 07973 632548 E-mail dan@attry.wanadoo.co.uk E-mail dan@attry.wanadoo.co.ukdan@attry.wanadoo.co.uk Chief Officer – Wyn Wattley Chief Officer – Wyn Wattley 07905 486935 07905 486935 E-mail wyn.wattley@blueyonder.co.uk E-mail wyn.wattley@blueyonder.co.ukwyn.wattley@blueyonder.co.uk